Latest receivables for STRM: $4.8M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest receivables for STRM is $4.8M as of April 2025. That compares with $5M in the prior-year period — down 3.6% year over year. Investors often review this figure alongside Streamline Health Solutions's historical trend and sector peers before judging valuation or financial health.
Over the past year, STRM's receivables moved from $5M to $4.8M — a 3.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Streamline Health Solutions's operating scale or balance-sheet position.
A receivables figure of $4.8M for STRM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting STRM's receivables ($4.8M), review year-over-year change from $5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Streamline Health Solutions's receivables against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.